Wells Fargo
LEXX icon

Wells Fargo’s Lexaria Bioscience LEXX Stock Holding History

Wells Fargo’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-133
Closed -$1.74K – 7258
2025
Q2 		$1.74K Hold
133
– – ﹤0.01% 6230
2025
Q1 		$3.42K Sell
133
-134
-50% -$3.41K ﹤0.01% 6086
2024
Q4 		$8.4K Buy
267
+100
+60% +$3.69K ﹤0.01% 5973
2024
Q3 		$7.63K Sell
167
-53
-24% -$2.53K ﹤0.01% 5853
2024
Q2 		$9.17K Buy
220
+148
+206% +$6.66K ﹤0.01% 5765
2024
Q1 		$3.9K Buy
72
+1
+1% +$38 ﹤0.01% 5932
2023
Q4 		$1.33K Sell
71
-1
-1% -$19 ﹤0.01% 6163
2023
Q3 		$1.09K Buy
72
+1
+1% +$14 ﹤0.01% 6182
2023
Q2 		$782 Hold
71
– – ﹤0.01% 6383
2023
Q1 		$2.91K Buy
71
+2
+3% +$85 ﹤0.01% 6171
2022
Q4 		$2.55K Hold
69
– – ﹤0.01% 5953
2022
Q3 		$2K Hold
69
– – ﹤0.01% 6160
2022
Q2 		$3K Hold
69
– – ﹤0.01% 6190
2022
Q1 		$3K Buy
69
+1
+1% +$57 ﹤0.01% 6585
2021
Q4 		$4K Buy
68
+66
+3,300% +$5.63K ﹤0.01% 6755
2021
Q3 		$0 Hold
2
– – ﹤0.01% 7270
2021
Q2 		$0 Hold
2
– – ﹤0.01% 7187
2021
Q1 		$0 Buy
+2
New +$176 ﹤0.01% 7154

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo's LEXX Position: Q3 2025 in Review

Wells Fargo sold out of Lexaria Bioscience (LEXX) in Q3 2025, closing a stake of 133 shares — an estimated $1.74K sold.

Wells Fargo first reported a position in LEXX in Q1 2021 and held it in 18 quarters. The position peaked at $9.17K in Q2 2024. 24 funds tracked by Wall St. Rank hold LEXX as of Q3 2025.

  • Wells Fargo reported no remaining Lexaria Bioscience position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 133 Lexaria Bioscience shares in Q3 2025, an estimated $1.74K.
  • Wells Fargo first reported a position in Lexaria Bioscience in Q1 2021 and held it in 18 quarters.
  • Wells Fargo's Lexaria Bioscience position peaked at $9.17K in Q2 2024.
  • 24 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.